{"_id": "52ce058038f0d81799290320", "print_page": null, "blog": [], "byline": {"person": [], "organization": "REUTERS", "original": "By REUTERS"}, "multimedia": [], "source": "Reuters", "type_of_material": "News", "news_desk": null, "snippet": "Japan's health ministry filed a criminal complaint against Novartis AG's local unit on Thursday after the pharmaceuticals company promoted its best-selling blood pressure drug Diovan using manipulated data....", "document_type": "article", "subsection_name": null, "word_count": "183", "headline": {"print_headline": "Japan Ministry Files Criminal Complaint Against Novartis Over Diovan", "main": "Japan Ministry Files Criminal Complaint Against Novartis Over Diovan"}, "lead_paragraph": "Japan's health ministry filed a criminal complaint against Novartis AG's local unit on Thursday after the pharmaceuticals company promoted its best-selling blood pressure drug Diovan using manipulated data.", "slideshow_credits": null, "keywords": [], "pub_date": "2014-01-08T21:09:04Z", "section_name": "Business Day", "abstract": null, "web_url": "http://www.nytimes.com/reuters/2014/01/08/business/08reuters-novartis-diovan-japan.html"}